The REDEMPTION-2 eTrial is now open to patients with Genotypes 1 2 3 4 5 and 6. That's right – all genotypes are invited! REDEMPTION-2 is using tablets containing generic Sovaldi® (Sofosbuvir 400 mg) and Daklinza® (Daclatasvir 60 mg) sourced from a variety of reputable manufacturers such as Incepta, Beacon, Julphar, and possibly Cipla, Hetero, … Continue reading REDEMPTION-2